Fact Check: Message about insulin price increase announcements originated as satire
A satirical X post saying the three major insulin manufacturers in the United States had announced 2,000%-3,000% price ...
Twin Cities Business12h
Minnesota AG Reaches Another Insulin Price Cap Settlement
Keith Ellison said he's reached a deal with Danish pharmaceutical company Novo Nordisk to keep the cost of insulin at $35 a ...
Albert Lea Tribune14h
Insulin capped at $35 per month for Minnesotans, after settlement with manufacturers
Minnesotans prescribed insulin won’t pay more than $35 per month for it, after the conclusion of a lawsuit against three ...
Eli Lilly price target lowered to $1,190 from $1,250 at Citi
Citi analyst Geoff Meacham lowered the firm’s price target on Eli Lilly to $1,190 from $1,250 and keeps a Buy rating on the shares. Ahead of ...
Peoples Democracy4d
GLP-1 drugs: Revolutionising Health, as Long as You’re Rich Enough
GLP-1 (glucagon-like peptide-1) discovered in the 1980s functions as a hormone derived from the proglucagon sequence and was found to have a transformative impact on the treatment of diabetes and ...
PharmiWeb5d
Glp-1 Analogues Market Share to Exceed USD 606.3 Billion by 2034
Glp-1 Analogues Market OverviewThe Glp analogues market size is expected to be worth USD 606.3 billion by 2034.The target market was valued at USD 45.3 billion in 2024.The market is projected to grow ...